Testosterone replacement therapy (TRT) is a common intervention for individuals with hypogonadism or low testosterone levels. Traditionally, intramuscular (IM) injections have been the standard route of administration for testosterone. However, emerging evidence suggests that subcutaneous (subQ) injections offer a viable and effective alternative.

Key Considerations

Bioavailability: SubQ injections involve administering testosterone into the fatty tissue just beneath the skin. Studies indicate that subQ administration provides comparable bioavailability to traditional IM injections. The slower absorption from subQ tissue can lead to a more stable release of testosterone.

Stable Testosterone Levels: SubQ injections may contribute to more stable testosterone levels throughout the dosing interval. This stability can potentially translate to a more consistent and predictable hormonal environment for individuals undergoing TRT.

Reduced Injection Discomfort: Patients often find subQ injections less painful than traditional IM injections. The smaller gauge needles used in subQ administration can contribute to a more comfortable experience, improving adherence to the prescribed treatment plan.

Flexible Dosing Schedule: SubQ injections offer the flexibility of a self-administration route. This can be particularly advantageous for patients who prefer to self-administer their medication, allowing them to follow a customized dosing schedule under healthcare provider guidance.

Minimized Intramuscular Trauma: IM injections, especially in the gluteal region, may inadvertently hit blood vessels or nerves, leading to discomfort or complications. SubQ injections, targeting the fatty layer beneath the skin, minimize the risk of intramuscular trauma.

Administration Technique

Needle Size and Depth: SubQ injections typically use smaller gauge needles (e.g., 27–30 gauge) compared to IM injections. The injection depth is usually shallower, typically around 3/8 to 5/8 inch. Proper training on injection technique is essential to ensure accurate administration.

Site Rotation: To prevent tissue irritation and enhance absorption, healthcare providers often recommend rotating injection sites. Common subQ injection sites include the abdomen and the front of the thigh. Consistent rotation helps maintain the integrity of the subcutaneous tissue.

Patient Education

Self-Administration Training: Educating patients on proper subQ injection techniques is crucial. This includes teaching them about the choice of injection site, needle insertion angle, and the importance of maintaining a sterile environment during the process.

Monitoring and Reporting: Patients should be encouraged to monitor for any adverse reactions at the injection site and report them promptly to their healthcare provider. Routine follow-ups can help assess the patient’s response to treatment and address any concerns. Subcutaneous injections represent a valuable option in testosterone replacement therapy, offering comparable efficacy to traditional intramuscular injections with potential advantages in terms of comfort, stability of testosterone levels, and patient adherence. As with any medical intervention, individual patient factors and preferences should guide the choice of administration route, emphasizing the importance of a patientcentered approach to TRT.